IDENTIFICATION OF A RECEPTOR CONTROLLING MIGRATION AND METASTASIS OF SKIN CANCER CELLS
    6.
    发明申请
    IDENTIFICATION OF A RECEPTOR CONTROLLING MIGRATION AND METASTASIS OF SKIN CANCER CELLS 审中-公开
    控制皮肤癌细胞迁移和转移的受体的鉴定

    公开(公告)号:US20080014586A1

    公开(公告)日:2008-01-17

    申请号:US11777907

    申请日:2007-07-13

    IPC分类号: C12Q1/68

    CPC分类号: C07K14/705

    摘要: The invention relates generally to genes expressed in skin cancer cells, particularly melanoma tumor cells, and their role in migration and metastasis. Methods for identifying melanoma cells are provided, as are methods of treating melanoma. Methods for identifying compounds that are useful in the treatment of melanoma are also provided.

    摘要翻译: 本发明一般涉及在皮肤癌细胞,特别是黑素瘤肿瘤细胞中表达的基因及其在迁移和转移中的作用。 提供用于鉴定黑素瘤细胞的方法,以及治疗黑素瘤的方法。 还提供了用于鉴定可用于治疗黑素瘤的化合物的方法。

    Identification of a receptor controlling migration and metastasis of skin cancer cells
    7.
    发明申请
    Identification of a receptor controlling migration and metastasis of skin cancer cells 审中-公开
    识别控制皮肤癌细胞迁移和转移的受体

    公开(公告)号:US20050196757A1

    公开(公告)日:2005-09-08

    申请号:US10601305

    申请日:2003-06-19

    CPC分类号: C07K14/705

    摘要: The invention relates generally to genes expressed in skin cancer cells, particularly melanoma tumor cells, and their role in migration and metastasis. Methods for identifying melanoma cells are provided, as are methods of treating melanoma. Methods for identifying compounds that are useful in the treatment of melanoma are also provided.

    摘要翻译: 本发明一般涉及在皮肤癌细胞,特别是黑素瘤肿瘤细胞中表达的基因及其在迁移和转移中的作用。 提供用于鉴定黑素瘤细胞的方法,以及治疗黑素瘤的方法。 还提供了用于鉴定可用于治疗黑素瘤的化合物的方法。

    PROSTATIC ACID PHOSPHATASE FOR THE TREATMENT OF PAIN
    9.
    发明申请
    PROSTATIC ACID PHOSPHATASE FOR THE TREATMENT OF PAIN 审中-公开
    用于治疗疼痛的前列腺酸磷酸酯酶

    公开(公告)号:US20100266569A1

    公开(公告)日:2010-10-21

    申请号:US12743110

    申请日:2008-11-17

    摘要: Methods and compositions are provided for the treatment of pain and cystic fibrosis. The methods include administering to an animal a composition or a pharmaceutical formulation comprising a therapeutically effective amount of a Prostatic Acid Phosphatase (“PAP”) polypeptide, or an active variant, fragment or derivative thereof, or a therapeutically effective amount of an activity enhancing PAP modulator. PAP is provided as a treatment for chronic pain including neuropathic and inflammatory pain in animals and humans. The PAP, or the active variant, fragment or derivative thereof, or the activity enhancing modulator of the PAP is administered via one or more of injection, intrathecal injection, oral administration, a surgically implanted pump, stem cells, viral gene therapy, or naked DNA gene therapy. Intrathecal injection of PAP functions as an analgesic and reduces thermal sensitivity in mice. PAP can reduce chronic mechanical and thermal inflammatory pain in mice. Allodynia and hyperalgesia due to nerve injury can be prevented by increasing PAP activity in spinal cord.

    摘要翻译: 提供方法和组合物用于治疗疼痛和囊性纤维化。 所述方法包括向动物施用包含治疗有效量的前列腺酸性磷酸酶(“PAP”)多肽或其活性变体,片段或衍生物或治疗有效量的活性增强PAP的组合物或药物制剂 调制器。 PAP作为慢性疼痛的治疗方法,包括动物和人类的神经性和炎性疼痛。 通过注射,鞘内注射,口服给药,手术植入的泵,干细胞,病毒基因治疗或裸体的PAP或其活性变体片段或衍生物或PAP的活性增强调节剂 DNA基因治疗。 鞘内注射PAP作为镇痛剂,降低小鼠的热敏感性。 PAP可以减少小鼠的慢性机械和热炎性疼痛。 通过增加脊髓中的PAP活性可以预防由于神经损伤引起的异常性疼痛和痛觉过敏。